Aprea Therapeutics, Inc. · NASDAQ:APRE

Stonepine Capital Management, LLC's stake in Aprea Therapeutics, Inc. fell to 4.30% (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 14, 2025

Stonepine Capital Management, LLC's stake in Aprea Therapeutics, Inc. fell to 4.30%, 239,416 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).

Stake
4.30%
Shares
239,416
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Stonepine Capital Management, LLC4.30%239,416
Stonepine Capital, L.P.4.30%239,416
Stonepine GP, LLC4.30%239,416
Jon M. Plexico4.30%239,416

Source

View original at SEC

Related